Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental Cohort.

Fiche publication


Date publication

décembre 2020

Journal

Brain sciences

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel


Tous les auteurs :
Yrondi A, Bennabi D, Haffen E, Quelard D, Samalin L, Maruani J, Allauze E, Pierre D, Bougerol T, Camus V, D'Amato T, Doumy O, Holtzmann J, Lançon C, Moliere F, Moirand R, Nieto I, Richieri RM, Horn M, Schmitt L, Stephan F, Genty JB, Vaiva G, Walter M, Courtet P, Leboyer M, Llorca PM, Marguet S, Dennis N, Schaetz D, El-Hage W, Aouizerate B

Résumé

Major depressive disorder (MDD) is among the most common psychiatric disorders. One-third of patients are usually unresponsive to several lines of treatment. This study aimed to describe the FondaMental French cohort of patients with treatment-resistant depression (TRD) and to estimate utility and healthcare resource use outcomes.

Mots clés

healthcare resource use, real-world, treatment-resistant depression, utility

Référence

Brain Sci. 2020 Dec 10;10(12):